연구성과로 돌아가기
2024 연구자 정보 (412 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Baek, Seol-Hee (Baek, SH) |
Korea Univ, Anam Hosp, Coll Med, Dept Neurol, Seoul, South Korea Korea Univ, Korea Univ Anam Hosp, Dept Neurol, Coll Med, Seoul, South Korea Korea Univ, Anam Hosp, Dept Neurol, Seoul, South Korea |
|
0000-0002-3656-1833 Baek, Seol-Hee |
[JCR상위 16.7] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders [JCR상위 4.7] Clinical profile and treatment outcomes of idiopathic intracranial hypertension: a multicenter study from Korea [JCR상위 25.2] Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study |
SCIE | 4.7 |
MEDICAL LABORATORY TECHNOLOGY CLINICAL NEUROLOGY;NEUROSCIENCES MEDICINE, GENERAL & INTERNAL |
juhongm@skku.edu; mijilee.md@snu.ac.kr;dowonc@naver.com; hayshin@yuhs.ac; |
||
|
Bai, Li-Yuan (Bai, LY) |
China Med Univ Hosp, Div Hematol & Oncol, Taichung, Taiwan China Med Univ, China Med Univ Hosp, Div Hematol & Oncol, Taichung, Taiwan |
|
|
[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis [JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial |
SCIE | 1.0 |
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
ykkang@amc.seoul.kr; msasako2010@yahoo.co.jp; |
||
|
Bera, Aishi (Bera, A) |
Heritage Inst Technol, Dept Biotechnol, Kolkata 700107, India |
|
|
[JCR상위 16.7] Harnessing exosomes as cancer biomarkers in clinical oncology | SCIE | 16.7 | ONCOLOGY | krishnana1@ufs.ac.za;prakashg@knu.ac.kr;abc2000@knu.ac.kr; | ||
|
Boku, Narikazu (Boku, N) |
Natl Canc Ctr, Tokyo, Japan Univ Tokyo Hosp, Inst Med Sci, Dept Oncol & Gen Med, Tokyo, Japan |
|
|
[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial [JCR상위 1.0] Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial |
SCIE | 1.0 |
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
ykkang@amc.seoul.kr; msasako2010@yahoo.co.jp; |
||
|
Chakraborty, Kashmira (Chakraborty, K) |
Indian Inst Technol Indian Sch Mines, Dept Chem & Chem Biol, Dhanbad 826004, Jharkhand, India |
|
|
[JCR상위 16.7] Harnessing exosomes as cancer biomarkers in clinical oncology | SCIE | 16.7 | ONCOLOGY | krishnana1@ufs.ac.za;prakashg@knu.ac.kr;abc2000@knu.ac.kr; | ||
|
Chan, Catherine (Chan, CTRE) |
Amgen Inc, Thousand Oaks, CA USA |
|
|
[JCR상위 16.7] Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis | SCIE | 16.7 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Chao, Yee (Chao, Y) |
Taipei Vet Gen Hosp, Taipei, Taiwan |
|
|
[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial | SCIE | 16.7 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Chau, Ian (Chau, I) |
Royal Marsden Hosp, Sutton, England |
ABC-2023-2020 Chau, Ian |
0000-0003-0286-8703 Chau, Ian |
[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial | SCIE | 16.7 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Choi, Cheol Ho (Choi, CH) |
교신저자 |
Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea Kyungpook Natl Univ, Dept Chem Educ, Daegu 41566, South Korea |
|
|
[JCR상위 16.7] Chemoexcited Formation and Radiationless Decay Dynamics of Firefly Chromophore [JCR상위 37.2] UMRSF-TDDFT: Unrestricted Mixed-Reference Spin-Flip-TDDFT [JCR상위 16.7] Temperature Controlled Decay and Pendulum Dynamics of Green Fluorescent Protein (GFP) Chromophore [JCR상위 11.5] OpenQP: A Quantum Chemical Platform Featuring MRSF-TDDFT with an Emphasis on Open-Source Ecosystem |
SCIE | 11.5 |
CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL CHEMISTRY, PHYSICAL;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL |
tzeng@yorku.ca;cchoi@knu.ac.kr; seunghoonlee@snu.ac.kr;cchoi@knu.ac.kr; dongho@yonsei.ac.kr;cchoi@knu.ac.kr; cchoi@knu.ac.kr; |
|
|
Chowdhury, Rajanyaa (Chowdhury, R) |
Heritage Inst Technol, Dept Biotechnol, Kolkata 700107, India |
|
|
[JCR상위 16.7] Harnessing exosomes as cancer biomarkers in clinical oncology | SCIE | 16.7 | ONCOLOGY | krishnana1@ufs.ac.za;prakashg@knu.ac.kr;abc2000@knu.ac.kr; | ||
|
Chung, Soo Young (Chung, SY) |
Dongnam Inst Radiol & Med Sci DIRAMS, Ctr Canc, Dept Pathol, Busan, South Korea |
|
|
[JCR상위 16.7] Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial | SCIE | 16.7 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | mckook@ncc.re.kr; | ||
|
Di Bartolomeo, Maria (Di Bartolomeo, M) |
Fdn IRCCS Ist Nazl Tumori, Milan, Italy |
D-1655-2017 Di Bartolomeo, Maria |
|
[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial | SCIE | 16.7 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Dubey, Amit (Dubey, A) |
Quanta Calculus, Computat Chem & Drug Discovery Div, Greater Noida, Uttar Pradesh, India Saveetha Inst Med & Tech Sci, Saveetha Dent Coll & Hosp, Dept Pharmacol, Chennai, Tamil Nadu, India |
AEK-6447-2022 Dubey, Amit |
|
[JCR상위 16.7] Harnessing exosomes as cancer biomarkers in clinical oncology | SCIE | 16.7 | ONCOLOGY | krishnana1@ufs.ac.za;prakashg@knu.ac.kr;abc2000@knu.ac.kr; | ||
|
Evesque, Ludovic (Evesque, L) |
Ctr Antoine Lacassagne, Nice, France |
|
|
[JCR상위 16.7] Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial | SCIE | 16.7 | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Farmani, Maryam (Farmani, M) |
제1저자 | Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea |
|
|
[JCR상위 16.7] Chemoexcited Formation and Radiationless Decay Dynamics of Firefly Chromophore | SCIE | 16.7 | CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, ATOMIC, MOLECULAR & CHEMICAL | tzeng@yorku.ca;cchoi@knu.ac.kr; |
페이지 이동: